CIK 0001133416 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in NV · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -30.8 M | -41.1 M | -38.8 M |
| Diluted EPS (USD/shares) | -0.48 | -0.74 | -0.65 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-13 | ARS | ARS | 2025-12-31 |
| 2026-10-13 | DEFA14A | DEFA14A | |
| 2026-10-13 | DEF 14A | DEF 14A | 2026-12-03 |
| 2026-10-02 | PRE 14A | PRE 14A | 2026-12-03 |
| 2026-08-14 | 8-K | 8-K items 2.02,9.01 | 2026-08-14 |
| 2026-08-14 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-08-04 | 4 | FORM 4 | 2026-07-31 |
| 2026-08-04 | 8-K | CURRENT REPORT FILING items 3.02,9.01 | 2026-07-31 |
| 2026-07-16 | 4 | FORM 4 | 2026-07-14 |
| 2026-06-30 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-30 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-29 | 144 | 144 | |
| 2026-06-26 | 144 | 144 | |
| 2026-06-26 | 144 | 144 | |
| 2026-06-25 | 4 | FORM 4 | 2026-06-23 |
| 2026-06-23 | 144 | 144 | |
| 2026-06-23 | 8-K | 8-K items 7.01,9.01 | 2026-06-23 |
| 2026-05-28 | 4 | FORM 4 | 2026-05-26 |
| 2026-05-15 | 8-K | 8-K items 2.02,9.01 | 2026-05-15 |
| 2026-05-15 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-10 | EFFECT | EFFECT items ,, | |
| 2026-04-08 | CORRESP | CORRESP | |
| 2026-04-06 | UPLOAD | UPLOAD | |
| 2026-03-31 | S-3 | S-3 |
Forms on file (last 1,000): 4 493, 8-K 242, 10-Q 45, 144 24, 4/A 24, 3 17, DEF 14A 15, 10-K 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GALT (0.002 USD), /gw/filings/filings?ticker=GALT&form=8-K, /gw/filings/facts?ticker=GALT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange